NT_1170x120_1-11-18

Lupin receives FDA approval for generic Lipitor

Print Friendly, PDF & Email
BALTIMORE  Lupin announced that it has received approval for its atorvastatin calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Pfizer’s Lipitor Tablets, 10 mg, 20 mg, 40 mg and 80 mg.

Lupin’s atorvastatin calcium tablets USP 10 mg, 20 mg, 40 mg, and 80 mg, is the generic version of Pfizer’s Lipitor Tablets, 10 mg, 20 mg, 40 mg and 80 mg. It is indicated to lower cholesterol in blood for adults and children over 10 years of age. Atorvastatin is also prescribed to lower the risk for heart attack, stroke in patients with cardiovascular diseases, diabetes and other risk factors such as eye problems, kidney diseases or high blood pressure.


EMC_728x90

INNOV_728x90_8-1-17

Comments are closed.